[Mutation spectrum analysis of 23-site chip neonatal deafness genetic screening]

Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2024 Apr;38(4):267-272. doi: 10.13201/j.issn.2096-7993.2024.04.001.
[Article in Chinese]

Abstract

Objective:To analyze the mutation spectrum of 23-site chip newborn deafness genetic screening in Beijing, and to provide basis for genetic counseling and clinical diagnosis and treatment. Methods:The study included 21 006 babies born in Beijing from December 2022 to June 2023. All subjects underwent newborn deafness genetic screening in Beijing Tongren Hospital, covering 23 variants in 4 genes, the GJB2 gene(c.35delG, c.176_191del16, c.235delC, c.299_300delAT, c.109G>A, c.257C>G, c.512insAACG, c.427C>T, c.35insG), SLC26A4 gene(c.919-2A>G, c.2168A>G, c.1174A>T, c.1226G>A, c.1229C>T, c.1975G>C, c.2027T>A, c.589G>A, c.1707+5G>A, c.917insG, c.281C>T), Mt12SrRNA(m.1555A>G, m.1494C>T) and GJB3 gene(c.538C>T). The mutation detection rate and allele frequency were analyzed. Results:The overall mutation detection rate was 11.516%(2 419/21 006), with the GJB2 gene being the most frequently involved at 9.097%(1 911/21 006), followed by the SLC26A4 gene at 2.123%(446/21 006), the GJB3 gene at 0.362%(76/21 006) and Mt12SrRNA at 0.176%(37/21 006). Among the GJB2 genes, c.109G>A and c.235delC mutation detection rates were the highest, with 6.579%(1 382/21 006) and 1.795%(377/21 006), respectively. Of the SLC26A4 genes, c.919-2A>G and c.2168A>G had the highest mutation rates of 1.423%(299/21 006) and 0.233%(49/21 106), respectively. Regarding the allele frequency, GJB2 c.109G>A was the most common variant with an allele frequency of 3.359%(1 411/42 012), followed by the GJB2 c.235delC at 0.897%(377/42 012) and the SLC26A4 c.919-2A>G at 0.719%(302/42 012). Conclusion:23-site chip newborn deafness genetic screening in Beijing showed that GJB2 c.109G>A mutation detection rate and allele frequency were the highest. This study has enriched the epidemiological data of 23-site chip genetic screening mutation profiles for neonatal deafness, which can provide evidence for clinical practice.

目的:分析北京市23项新生儿耳聋基因筛查的突变频谱,为遗传咨询及临床诊疗提供依据。 方法:研究对象为2022年12月-2023年6月在首都医科大学附属北京同仁医院接受23项耳聋基因筛查的新生儿21 006例。23项耳聋基因筛查包括4个基因23个位点:GJB2基因(c.35delG、c.176_191del16、c.235delC、c.299_300delAT、c.109G>A、c.257C>G、c.512insAACG、c.427C>T、c.35insG)、SLC26A4基因(c.919-2A>G、c.2168A>G、c.1174A>T、c.1226G>A、c.1229C>T、c.1975G>C、c.2027T>A、c.589G>A、c.1707+5G>A、c.917insG、c.281C>T)、线粒体12SrRNA基因(m.1555A>G、m.1494C>T)和GJB3基因(c.538C>T)。分析各基因位点的突变率及等位基因突变频率。 结果:21 006例中,耳聋基因筛查未通过率11.516%(2 419/21 006)。4个基因中GJB2基因突变率最高,为9.097%(1 911/21 006),其次分别为SLC26A4基因2.123%(446/21 006)、GJB3基因0.362%(76/21 006)及线粒体12SrRNA基因0.176%(37/21 006)。GJB2基因中,c.109G>A和c.235delC突变率最高,分别为6.579%(1 382/21 006)和1.795%(377/21 006)。SLC26A4基因中,c.919-2A>G和c.2168A>G突变率最高,分别为1.423%(299/21 006)和0.233%(49/21 006)。等位基因突变频率,GJB2基因c.109G>A最高,为3.359%(1 411/42 012),其次为GJB2基因c.235delC,0.897%(377/42 012)及SLC26A4基因c.919-2A>G,0.719%(302/42 012)。 结论:北京市23项新生儿耳聋基因筛查提示,GJB2基因c.109G>A突变率和等位基因突变频率最高,值得临床重视。本研究丰富了23项新生儿耳聋基因筛查突变频谱的流行病学资料,可为临床提供依据。.

Keywords: allele frequency; deafness genes; mutation detection rate; newborn.

Publication types

  • English Abstract

MeSH terms

  • China
  • Connexin 26 / genetics
  • Connexins / genetics
  • DNA Mutational Analysis
  • Deafness* / diagnosis
  • Deafness* / genetics
  • Genetic Testing
  • Hearing Loss* / genetics
  • Humans
  • Infant
  • Infant, Newborn
  • Mutation
  • Neonatal Screening
  • Sulfate Transporters / genetics

Substances

  • Connexins
  • Connexin 26
  • Sulfate Transporters